JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Dine Brands
DIN
$440M
| $2.03M | ﹤0.01% |
24,285
-2,038
| -8% | -$158K |
|
3227
Albany International
AIN
$1.82B
| $2.02M | ﹤0.01% |
26,644
-13,549
| -34% | -$1.13M |
|
|
AQUA
3228
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $2.02M | ﹤0.01% |
106,682
+82,135
| +335% | +$1.47M |
|
3229
Bristow Group
VTOL
$1.38B
| $2.02M | ﹤0.01% |
99,339
-10,991
| -10% | -$218K |
|
3230
PUT
Pitney Bowes
PBI
$2.28B
| $2.02M | ﹤0.01% |
500,000
| – | – |
|
3231
Daktronics
DAKT
$988M
| $2.01M | ﹤0.01% |
330,383
+194,000
| +142% | +$1.3M |
|
3232
iShares Core S&P US Growth ETF
IUSG
$34B
| $2.01M | ﹤0.01% |
29,757
-672
| -2% | -$43.5K |
|
3233
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.73B
| $2.01M | ﹤0.01% |
27,358
| – | – |
|
3234
Cardlytics
CDLX
$25.1M
| $2.01M | ﹤0.01% |
3,195
-25,755
| -89% | -$12.6M |
|
3235
CALL
Dave & Buster's
PLAY
$370M
| $2.01M | ﹤0.01% |
+50,000
| New | +$2M |
|
|
ZYNE
3236
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $2.01M | ﹤0.01% |
332,484
-37,355
| -10% | -$255K |
|
3237
PUT
CVS Health
CVS
$121B
| $2.01M | ﹤0.01% |
27,000
+100
| +0.4% | +$7.02K |
|
3238
Frontdoor
FTDR
$5.83B
| $2M | ﹤0.01% |
42,293
-108,244
| -72% | -$5.07M |
|
|
AYX
3239
CALL
DELISTED
Alteryx Inc
AYX
| $2M | ﹤0.01% |
+20,000
| New | +$2.03M |
|
|
CRC
3240
DELISTED
California Resources Corporation
CRC
| $2M | ﹤0.01% |
221,575
-393,974
| -64% | -$3.19M |
|
|
TSC
3241
DELISTED
TriState Capital Holdings, Inc.
TSC
| $2M | ﹤0.01% |
76,462
+11,079
| +17% | +$264K |
|
3242
Cactus
WHD
$5.78B
| $2M | ﹤0.01% |
58,163
+28,787
| +98% | +$874K |
|
3243
iShares Core 10+ Year USD Bond ETF
ILTB
$595M
| $2M | ﹤0.01% |
29,291
+20,209
| +223% | +$1.39M |
|
3244
Invesco Large Cap Growth ETF
PWB
$2.45B
| $1.99M | ﹤0.01% |
38,705
-4,737
| -11% | -$233K |
|
3245
PUT
The Mosaic Company
MOS
$6.92B
| $1.98M | ﹤0.01% |
91,500
| – | – |
|
3246
Casella Waste Systems
CWST
$5.79B
| $1.98M | ﹤0.01% |
42,968
+9,759
| +29% | +$430K |
|
3247
CALL
Campbell Soup
CPB
$6.94B
| $1.98M | ﹤0.01% |
40,000
| – | – |
|
|
NOA
3248
North American Construction
NOA
$389M
| $1.97M | ﹤0.01% |
162,905
-20,061
| -11% | -$224K |
|
|
CETV
3249
DELISTED
Central European Media Enterprises Ltd
CETV
| $1.97M | ﹤0.01% |
434,986
+90,677
| +26% | +$409K |
|
|
3250
CALL
The Mosaic Company
MOS
$6.92B
| $1.97M | ﹤0.01% |
91,000
| – | – |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.